Realizing the Potential of the Patient Perspective

Abstract

Assessing a patient’s perspective on their treatment is part of an increasingly integrated approach to pharmacovigilance and treatment optimization. New tools and methods developed in partnership with patients can capture and quantify cognitive and behavioral aspects of the treatment experience. These treatment insights have the potential to shape the drug development process, as well as supplement patient-reported outcome data in a way that is meaningful to the patient. We highlight examples of tools developed to assess the impact of treatment on the aspects of disease that are of utmost concern to the patient in their daily life.

Keywords:

• drug development
• patient engagement
• patient perspective
• patient-reported outcome

Acknowledgments

All opinions expressed are those of the authors. Editorial and writing assistance was provided by Linda Brown and Lola Parfitt of Caudex, Oxford, UK, and was funded by Bristol Myers Squibb. John H. Simon developed the Patient Reported Effects Elicitation Tool (PRE²T).

Disclosure

Teresa A Simon is a former employee and shareholder of Bristol Myers Squibb; Marlene S. Khouri, Tzuyung Kou, and Andres Gomez-Caminero are all current employees of Bristol Myers Squibb. The authors report no other conflicts of interest in this work.

Additional information

Funding

Funding for this commentary was provided by Bristol Myers Squibb.